Author

J. Ruwaard

Observed names: J Ruwaard, JILL RUWAARD, Jill Ruwaard, Ruwaard, J

Observed institution: Reade

OpenAlex ID: A5035683230

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

2019 · Lea C. Berkhout, Merel J. l’Ami, et al. · Science Translational Medicine · 64

Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial

2022 · J Ruwaard, MJ L’ Ami, et al. · Scandinavian Journal of Rheumatology · 27

PDF

Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab

2017 · J Ruwaard, MJ l’Ami, et al. · Scandinavian Journal of Rheumatology · 15

PDF

Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis

2019 · MJ l’ Ami, J Ruwaard, et al. · Scandinavian Journal of Rheumatology · 14

PDF

Search for a concentration–effect curve of adalimumab in ankylosing spondylitis patients

2016 · AF Marsman, EL Kneepkens, et al. · Scandinavian Journal of Rheumatology · 11

Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice

2019 · Zohra Layegh, Jill Ruwaard, et al. · International Journal of Rheumatic Diseases · 10

SAT0189 Dynamics of circulating tnf during adalimumab treatment of rheumatoid arthritis using a novel drug-tolerant tnf assay

2018 · L.C. Berkhout, M.J. l'Ami, et al. · Annals of the Rheumatic Diseases · 6

PDF

AB1279 Efficacious transition from reference product infliximab to the biosimilar in daily practice

2018 · Z. Layegh, J. Ruwaard, et al. · Annals of the Rheumatic Diseases · 5

PDF

Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication

2024 · Femke Hooijberg, Zohra Layegh, et al. · Therapeutic Drug Monitoring · 2

Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data.

2019 · Jill Ruwaard, Anneke F Marsman, et al. · PubMed · 2

Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy

2018 · JILL RUWAARD, EVA R. VAN DER VLUGT, et al. · The Journal of Rheumatology · 2

PDF

THU0211 Six months after treatment discontinuation tnf is still in complex with adalimumab

2018 · M.J. l'Ami, L.C. Berkhout, et al. · Annals of the Rheumatic Diseases · 2

PDF

SAT0433 Anti-tnf treatment in rheumatoid arthritis and ankylosing spondylitis patients is associated with a strong increase of palmoplantar pustulosis but not of psoriasis vulgaris

2017 · J Ruwaard, E van der Vlugt, et al. · Annals of the Rheumatic Diseases · 2

PDF

THU0208 Efficacy of Switching Tumor Necrosis Factor α Inhibitor to a Second Tumor Necrosis Factor α Inhibitor and the Influence of Drug Levels and Anti-Drug Antibodies in Patients with Ankylosing Spondylitis and Psoriatic Arthritis

2015 · J. Ruwaard, E. Kneepkens, et al. · Annals of the Rheumatic Diseases · 2

Op0209 Interval Prolongation in Etanercept-treated Patients With Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis: an Open-label, Randomised Controlled Trial

2020 · M.J. L'ami, J. Ruwaard, et al. · Annals of the Rheumatic Diseases · 1

PDF

AB0324 Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis

2016 · M.J. l'Ami, A.F. Marsman, et al. · Annals of the Rheumatic Diseases · 1

SAT0156 The Effect of Methotrexate in Treatment with Adalimumab And Etanercept in Patients with Rheumatoid Arthritis

2015 · M. l'Ami, E. Kneepkens, et al. · Annals of the Rheumatic Diseases · 1

TNF Inhibition in Transition

2026 · Jill Ruwaard

OP0112 Therapeutic drug monitoring to optimise switching between biologic agents in rheumatoid arthritis

2018 · M.J. l'Ami, J. Ruwaard, et al. · Annals of the Rheumatic Diseases

PDF

FRI0125 Quantification of tumour necrosis factor in ankylosing spondylitis patients during adalimumab treatment

2018 · L. Berkhout, J. Ruwaard, et al. · Annals of the Rheumatic Diseases

PDF

FRI0713-HPR The patients' perspectives towards the provision of information during transition to a biosimilar

2018 · J. Kreuk, A. Twisk, et al. · Annals of the Rheumatic Diseases

PDF

FRI0707 Drug levels and antidrug antibodies in the development of paradoxical psoriasis and palmoplantar pustulosis

2017 · J Ruwaard, E van der Vlugt, et al. · Annals of the Rheumatic Diseases

OP0025 Antidrug antibodies detection is strongly influenced by the type of assay used

2017 · J Ruwaard, AF Marsman, et al. · Annals of the Rheumatic Diseases

PDF

SAT0397 Comparison of Long-Term Drug Survival Outcome with Etanercept Treatment and Adalimumab Treatment of Ankylosing Spondylitis

2016 · J. Ruwaard, M. l'Ami, et al. · Annals of the Rheumatic Diseases

THU0243 A Concentration-Effect Curve of Adalimumab in Ankylosing Spondylitis Patients; Does it Exist or Not?

2015 · A. Marsman, E. Kneepkens, et al. · Annals of the Rheumatic Diseases

Works count: 28

Citation count: 167

H-index: 6

I10-index: 6